| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |